EGCG (50–350 μM; 72 h) caused cell cycle arrest and decreased cell viability by inhibiting DNMT activity and inducing RXRα promoter hypomethylation and expression in human colon cancer cells [202]. This evidence concerns the gene DNMT1 and colonic neoplasm.